LUISA SANTOS: Open Payments
NPI 1265747604 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 15 payments from 8 companies in 2025. Trend: 2023 $175 · 2024 $176 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Recor Medical Inc | 1 | $26 |
| Novo Nordisk Inc | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: LEQVIO, CAMZYOS, ELIQUIS, JARDIANCE, Paradise Ultrasound Renal Denervation System, Ozempic, NEXLIZET, Kerendia.
Industry payments across NY — which companies pay providers there.
